Mary Reumuth

Companies

• Kala Pharmaceuticals (United States)Chief financial officer Jul 19, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKala Pharmaceuticals (United States) KALA28,906 shares²$5.8K at $0.20Oct 23, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Oct 23, 2025Sold 967 shares at $0.82 of Kala Pharmaceuticals (United States)²
• Oct 22, 2025Sold 32,230 shares at $0.83 of Kala Pharmaceuticals (United States)²
• Jun 24, 2025Sold 3,631 shares at $4.01 of Kala Pharmaceuticals (United States)³
• Jun 3, 2025Sold 2,850 shares at $3.74 of Kala Pharmaceuticals (United States)⁴
• Jan 6, 2025Sold 1,706 shares at $7.63 of Kala Pharmaceuticals (United States)⁵
• Jan 6, 2025Granted 10,100 shares of Kala Pharmaceuticals (United States)⁵
• Jun 26, 2024Sold 4,163 shares at $4.75 of Kala Pharmaceuticals (United States)⁶
• May 31, 2024Sold 1,786 shares at $6.09 of Kala Pharmaceuticals (United States)⁷
• Jan 4, 2024Sold 1,227 shares at $6.74 of Kala Pharmaceuticals (United States)⁸
• Jan 4, 2024Granted 4,600 shares of Kala Pharmaceuticals (United States)⁸
• Jun 22, 2023Granted 36,144 shares of Kala Pharmaceuticals (United States)⁹
• May 31, 2023Granted 14,736 shares of Kala Pharmaceuticals (United States)¹⁰
• Jan 4, 2023Sold 60 shares at $28.54 of Kala Pharmaceuticals (United States)¹¹
• Jan 4, 2023Granted 9,525 shares of Kala Pharmaceuticals (United States)¹¹
• Oct 26, 2022Sold 194 shares at $6.51 of Kala Pharmaceuticals (United States)¹²
• Jun 27, 2022Sold 2,613 shares at $0.37 of Kala Pharmaceuticals (United States)¹³
• Jan 4, 2022Sold 2,850 shares at $1.30 of Kala Pharmaceuticals (United States)¹⁴
• Oct 26, 2021Sold 9,449 shares at $1.80 of Kala Pharmaceuticals (United States)¹⁵